What best defines pharmacovigilance within the social construction framework?

• A. It is the marketing discipline for drugs
• B. It is the science of detecting adverse drug effects; social factors influence safety reporting and trust
• C. It studies pharmacokinetics without social considerations
• D. It only concerns regulatory approval processes

Answer: (B)

Pharmacovigilance within a social construction framework centers on how safety signals about drugs are identified, interpreted, and acted upon through social processes. It treats the science of detecting adverse drug effects as inseparable from how people report them, how clinicians assess them, and how trust in healthcare systems, cultural norms, media coverage, and regulatory practices shape what gets noticed and what doesn’t. This perspective highlights that safety reporting is not purely objective data collection; it is influenced by social factors that affect reporting rates, the credibility given to reports, and the subsequently taken risk-management actions.

This is why the best choice emphasizes both the detection of adverse drug effects and the social factors that influence safety reporting and trust. The other options miss this social dimension: marketing concerns promotion rather than surveillance; pharmacokinetics without social context ignores patient and clinician reporting behaviors; and regulatory approvals focus on authorization, not the lived social processes that generate and interpret safety information.